Effect of combined oral proteases and flavonoid treatment in subjects at risk of Type 1 diabetes.
Kempf
K
K
Manzo
G
G
Hanifi-Moghaddam
P
P
Kappler
S
S
Seissler
J
J
Jaeger
C
C
Boehm
B
B
Roden
M
M
Kolb
H
H
Martin
S
S
Schloot
N C
NC
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001963:Bromelains / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000453:epidemiology / Q000628:therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005419:Flavonoids / Q000627:therapeutic use*; D006801:Humans; D015994:Incidence; D010447:Peptide Hydrolases / Q000627:therapeutic use*; D010919:Placebos; D011446:Prospective Studies; D012306:Risk; D012431:Rutin / Q000627:therapeutic use; D014357:Trypsin / Q000627:therapeutic use; D055815:Young Adult
D016207:Cytokines; D005419:Flavonoids; D010919:Placebos; D012431:Rutin; D001963:Bromelains; D010447:Peptide Hydrolases; D014357:Trypsin